FDA updates guidance on ventilator splitting

The FDA updated guidelines on the use of ventilator tubing connectors, or ventilator splitters, based on a recent literature review in a Feb. 9 letter.

In anticipation of shortages, the agency authorized emergency use of certain ventilators and ventilator accessories for treating patients during the COVID-19 pandemic in March. 

Ventilator splitters should be considered a last option, the guidance said. Healthcare providers should first consider noninvasive alternatives such as high flow nasal oxygen or positive pressure ventilation. 

If invasive ventilation using an authorized splitter is the only alternative, the FDA guidance recommends the following: 

-Limit ventilation sharing to two patients. 

-Try to match patients based on similar ventilatory requirements.

-Limit sharing ventilation to 48 hours.

-Reserve at least one single-patient ventilator for emergencies. 

-Consider updated ventilator sharing protocols to minimize risk.

To read the full letter, click here.

More articles on patient safety and outcomes:
Intermountain changes mammogram guidelines for women who get COVID-19 vaccine
Joint Commission starts public reporting of 2 perinatal care measures
ICU deaths have fallen among COVID-19 patients, but progress is stalling

 

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Whitepapers

Featured Webinars